5.70 (-%)
As of Nov 04, 2024
Source:
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company with a mission to end the suffering caused by neurodegenerative diseases.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (617) 682-0917 |
Industry | manufacturing |
CEO | Joshua B. Cohen & Justin B. Klee |
Website | www.amylyx.com |